- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 37.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 37.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 36.73M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $3.76M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $8.32M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9.75M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $20.22M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $475.11M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $474.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $109.73M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $138.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $731.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $745.43M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $564.86M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $574.12M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.33B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.35B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.19M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.55M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$17.49M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$49.38M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$305K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$12.3M |
| Revenue | Q1 2026 · Mar 31, 2026 | $25.66M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $28.71M |